Functional Assessment of the BMPR2 Gene in Lymphoblastoid Cell Lines from Graves' Disease Patients

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2017 Dec 22

PMID 29266775

Authors

Guillermo Pousada

Mauro Lago-Docampo

Sonia Prado

Ruben Varela-Calvino

Beatriz Mantinan

Diana Valverde

Affiliations

Soon will be listed here.

Abstract

In this study, we analysed the possible influence of the c.419-43delT BMPR2 variant in patients with Graves' disease (GD), in a molecular basis, focusing our efforts on possible alterations in the mRNA processing and synthesis. The molecular assessment of this variant in patients with GD would shed light on the association between the BMPR2 gene and the disease. The variant was detected in 18%, 55% and 10% of patients with pulmonary arterial hypertension, GD and in general population, respectively. Patients with GD fold change showed increased BMPR2 expression when matched against the controls, with a mean of 4.21 ± 1.73 (P = 0.001); BMPR2 was overexpressed in the analysed cell cycle stages. Fold change analysis of variant carriers and non-carriers showed slight overexpression and differences between phases, but none of them were statistically significant. BMPR2 expression was confirmed in the lymphoblastoid cell lines (LCLs) with a molecular weight of 115 kD, and no differences between variant carriers and non-carriers were detected. To conclude, the BMPR2 variant c.419-19delT appears in high frequency in patients with GD, and independently of its presence, BMPR2 is overexpressed in the LCLs from the GD patients tested. This increase could be paired with the described decreased expression of transforming growth factor-β1 in thyroid tissue from patients with GD.

References

Fang Y, Yu S, Braley-Mullen H . TGF-β promotes proliferation of thyroid epithelial cells in IFN-γ(-/-) mice by down-regulation of p21 and p27 via AKT pathway. Am J Pathol. 2011; 180(2):650-60. PMC: 3349845. DOI: 10.1016/j.ajpath.2011.10.009. View

Hoeper M, Bogaard H, Condliffe R, Frantz R, Khanna D, Kurzyna M . Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 Suppl):D42-50. DOI: 10.1016/j.jacc.2013.10.032. View

Menconi F, Marcocci C, Marino M . Diagnosis and classification of Graves' disease. Autoimmun Rev. 2014; 13(4-5):398-402. DOI: 10.1016/j.autrev.2014.01.013. View

Nicolussi A, DInzeo S, Santulli M, Colletta G, Coppa A . TGF-beta control of rat thyroid follicular cells differentiation. Mol Cell Endocrinol. 2003; 207(1-2):1-11. DOI: 10.1016/s0303-7207(03)00238-7. View

Phillips 3rd J, Poling J, Phillips C, Stanton K, Austin E, Cogan J . Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension. Genet Med. 2008; 10(5):359-65. DOI: 10.1097/GIM.0b013e318172dcdf. View

Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J . qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007; 8(2):R19. PMC: 1852402. DOI: 10.1186/gb-2007-8-2-r19. View

Tomer Y, Huber A . The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun. 2009; 32(3-4):231-9. PMC: 3561494. DOI: 10.1016/j.jaut.2009.02.007. View

Kudo T, Kanetaka H, Watanabe A, Okumoto A, Asano M, Zhang Y . Investigating bone morphogenetic protein (BMP) signaling in a newly established human cell line expressing BMP receptor type II. Tohoku J Exp Med. 2010; 222(2):121-9. DOI: 10.1620/tjem.222.121. View

West J, Cogan J, Geraci M, Robinson L, Newman J, Phillips J . Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance. BMC Med Genomics. 2008; 1:45. PMC: 2561034. DOI: 10.1186/1755-8794-1-45. View

10.

Matsuo S, Fiore A, Siguematu S, Ebina K, Friguglietti C, Ferro M . Expression of SMAD proteins, TGF-beta/activin signaling mediators, in human thyroid tissues. Arq Bras Endocrinol Metabol. 2010; 54(4):406-12. DOI: 10.1590/s0004-27302010000400010. View

11.

Pousada G, Baloira A, Vilarino C, Cifrian J, Valverde D . Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension. PLoS One. 2014; 9(6):e100261. PMC: 4061078. DOI: 10.1371/journal.pone.0100261. View

12.

Bleul C, Boehm T . BMP signaling is required for normal thymus development. J Immunol. 2005; 175(8):5213-21. DOI: 10.4049/jimmunol.175.8.5213. View

13.

Schleinitz D, Kloting N, Bottcher Y, Wolf S, Dietrich K, Tonjes A . Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity. PLoS One. 2011; 6(2):e16155. PMC: 3032727. DOI: 10.1371/journal.pone.0016155. View

14.

Pisarev M, Thomasz L, Juvenal G . Role of transforming growth factor beta in the regulation of thyroid function and growth. Thyroid. 2009; 19(8):881-92. DOI: 10.1089/thy.2007.0303. View

15.

Badesch D, Raskob G, Elliott C, Krichman A, Farber H, Frost A . Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2009; 137(2):376-87. DOI: 10.1378/chest.09-1140. View

16.

Zhang J, Wang Y, Li D, Jing S . Notch and TGF-β/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma. Tumour Biol. 2013; 35(1):379-85. DOI: 10.1007/s13277-013-1053-z. View

17.

McGoon M, Benza R, Escribano-Subias P, Jiang X, Miller D, Peacock A . Pulmonary arterial hypertension: epidemiology and registries. J Am Coll Cardiol. 2013; 62(25 Suppl):D51-9. DOI: 10.1016/j.jacc.2013.10.023. View

18.

Simonneau G, Gatzoulis M, Adatia I, Celermajer D, Denton C, Ghofrani A . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 Suppl):D34-41. DOI: 10.1016/j.jacc.2013.10.029. View

19.

Pfarr N, Fischer C, Ehlken N, Becker-Grunig T, Lopez-Gonzalez V, Gorenflo M . Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension. Respir Res. 2013; 14:3. PMC: 3547748. DOI: 10.1186/1465-9921-14-3. View

20.

Galie N, Humbert M, Vachiery J, Gibbs S, Lang I, Torbicki A . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):.... Eur Heart J. 2015; 37(1):67-119. DOI: 10.1093/eurheartj/ehv317. View